Evidence map›Paper›PMID 33283227›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

The Spectrum of Tuberculosis Disease in an Urban Ugandan Community and Its Health Facilities.

Emily A Kendall, Peter J Kitonsa, Annet Nalutaaya, K Caleb Erisa, James Mukiibi, Olga Nakasolya, David Isooba, Yeonsoo Baik, Katherine O Robsky, Midori Kato-Maeda and 3 more

Open access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics.European respiratory review : an official journal of the European Respiratory Society · 2024
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Mobility patterns, activity locations, and TB in Nairobi, Kenya.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2025
    Article
  16. Active search for tuberculosis in three youth detention centers in Peru.Revista peruana de medicina experimental y salud publica · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Emily A KendallDivision of Infectious Diseases and Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Peter J KitonsaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
Annet NalutaayaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
K Caleb ErisaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
James MukiibiUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
Olga NakasolyaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
David IsoobaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
Yeonsoo BaikDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Katherine O RobskyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Midori Kato-MaedaDivision of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Adithya CattamanchiUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
Achilles KatambaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
David W DowdyUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
Makerere University · UGJohns Hopkins University · USUniversity of California, San Francisco · US

Funding

Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trialR01HL138728 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI David Wesley Dowdy, Emily A Kendall · 2017 to 2026
$5.4M
Translational modeling of individual- and population-level outcomes of novel tuberculosis drug regimensK08AI127908 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KENDALL, EMILY A · 2017 to 2021
$879k
FIC NIH HHS D43 TW010540NHLBI NIH HHS R01 HL138728NIAID NIH HHS K08 AI127908
6 · The paper itself

Abstract

backgroundNew, sensitive diagnostic tests facilitate identification and investigation of milder forms of tuberculosis (TB) disease. We used community-based TB testing with the Xpert MTB/RIF Ultra assay ("Ultra") to characterize individuals with previously undiagnosed TB and compare them to those from the same community who were diagnosed with TB through routine care.

methodsWe offered community-based sputum Ultra testing to adult residents of a well-defined area (population 34 000 adults) in Kampala, Uganda, via door-to-door screening and venue-based testing, then used detailed interview and laboratory testing to characterize TB-positive individuals. We compared these individuals to residents diagnosed with pulmonary TB at local health facilities and a representative sample of residents without TB (controls).

resultsOf 12 032 residents with interpretable Ultra results, 113 (940 [95% confidence interval {CI}, 780-1130] per 100 000) tested positive, including 71 (63%) positive at the lowest (trace) level. A spectrum of TB disease was observed in terms of chronic cough (93% among health facility-diagnosed cases, 77% among residents with positive community-based Ultra results at levels above trace, 33% among trace-positive community participants, and 18% among TB-negative controls), TB symptom prevalence (99%, 87%, 60%, and 38%, respectively), and C-reactive protein (75th percentile: 101 mg/L, 28 mg/L, 6 mg/L, and 4 mg/L, respectively). Community-diagnosed cases were less likely than health facility-diagnosed cases to have human immunodeficiency virus coinfection or previous TB. The specificity of Ultra was 99.4% (95% CI, 99.2%-99.5%) relative to a single spot sputum culture.

conclusionsPeople with undiagnosed prevalent TB in the community have different characteristics than those diagnosed with pulmonary TB in health facilities. Newer diagnostic tests may identify a group of people with early or very mild disease.

Indexed as

Antibiotics, AntitubercularMycobacterium tuberculosisTuberculosisAdultDrug Resistance, BacterialHealth FacilitiesHumansRifampinSensitivity and SpecificitySputumUgandaAntibiotics, AntitubercularRifampinactive case-findingprevalent tuberculosissubclinical tuberculosisXpert MTB/RIF Ultra

Identifiers

PMID33283227
PMCPMC8204779
OpenAlexW3112267403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.